The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in the treatment of scalp Seborrheic Dermatitis.
The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in association with an antifungal shampoo (Ketoconazole 2%) in the treatment of moderate to severe scalp Seborrheic Dermatitis compared to the antifungal shampoo alone.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
326
Association: clobetasol propionate shampoo \& ketoconazole shampoo
Association: clobetasol propionate shampoo \& ketoconazole shampoo
Monotherapy with clobetasol propionate shampoo
Galderma Investigational Center
Bruges, Belgium
Galderma Investigational Center
Brussels, Belgium
Total Severity Score (TSS): Percent Change From Baseline at Week 4
Total Severity Score (TSS) is sum of erythema, scaling and pruritus severity scores of the lesions evaluated each on a 4-point scale from 0 = None to 3 = Severe by the investigator. So minimum TSS can be 0 and maximum 9.
Time frame: baseline and week 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Monotherpay ketoconazole shampoo (2/week)
Galderma Investigational Center
Geel, Belgium
Galderma Investigational Center
Ghent, Belgium
Galderma Investigational Center
Liège, Belgium
Galderma Investigational Center
Mons, Belgium
Galderma Investigational Center
Paris, France
Galderma Investigational Center
Berlin, Germany
Galderma Investigational Center
Bonn, Germany
Galderma Investigational Center
Hamburg, Germany
...and 8 more locations